Industry Partnering Solutions Accelevir partners with pharmaceutical, biotechnology and diagnostic companies to implement assays that quantify and characterize low frequency targets. Our strategy includes operational scalability to support partner therapeutic programs from pre-clinical development through FDA-approval.


Clinical and Discovery Research

Accelevir leverages cutting edge technologies and platforms to develop custom fit-for-purpose solutions. We have a track record of consulting with our partners to develop a roadmap specific for each drug development and discovery program.

Contact our team to learn how Accelevir can support your custom assay development needs


Clinical Development and Trials

Accelevir has implemented LDMS by Frontier Science Foundation to support the AIDS Clinical Trials Group (ACTG) testing program.

Our expanded HIPAA compliant Laboratory Information System (LIMS) supported by CGM/LABDAQ is in implementation phase.

Our standard operating procedures are designed to  scale both routine and complex sample processing methods across a variety of sample types.  Through an interactive process Accelevir will assist in creating and implementing customized workflows from Research Use Only (RUO), Investigational Use Only(IUO) and ultimately Companion Diagnostic (CDx).

Contact our team to learn how Accelevir can support your clinical trial testing requirements


Companion Diagnostic Partnering

Accelevir aims to bring its core expertise in ultra rare target quantitation and quality control systems to support companion diagnostic assay qualification programs. We adopt a high-touch approach, working closely with our partners to understand biomarker integration and programmatic goals.

Contact our team to learn how Accelevir can provide tailored CDx support to accelerate your clinical development program

Accelevir | © 2023